[Partial laryngectomies at the University Hospital Center of Dakar].
Our experience on partial laryngectomies stretched on a period of 16 years. In an unfavorable medical environment, we issue our indicative criteria throughout this experience. From January 1st 1981 to December, 31st 1996, 14 patients have had a partial laryngectomy in University Hospital Center of Dakar. The average year was 56 and the sex-ratio was 1 woman out of 13 men. There were 13 carcinomas and 1 cas of acute dysplasia. 4 patients have had vertical partial laryngectomy, 5 have had a horizontal partial laryngectomy and 5 a partial laryngectomy on the upper out of the cricoid cartilage with the ganglia. After a 3 years close look, on 10 patients, we noted that 1 died, 1 disappeared, and 8 still were living. Carcinological failures consisted in 3 development by stages and 1 cas of a 2nd localisation. As for as functional results, the removal of the nozzle and the elimination of the nasogastric grohe of supply, were effective for respective average allotted time of 11 and 12 days. This laryngeal partial surgery seem scarce in our practice (12% of the patient who have had it). The improvement of results go to the choice of indications, the information the formation and the acquisition of technical stools more efficient.
Diallo
B K
BK
Service d'ORL et de Chirurgie Cervico-Faciale du CHU de Dakar, Sénégal.
Diouf
R
R
Tall
A
A
Ndiaye
I C
IC
Kpemissi
E
E
Diop
E M
EM
D000046:Academic Medical Centers; D000328:Adult; D017677:Age Distribution; D003413:Cricoid Cartilage / Q000601:surgery; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007441:Intubation, Gastrointestinal; D007822:Laryngeal Neoplasms / Q000453:epidemiology / Q000473:pathology / Q000601:surgery*; D007825:Laryngectomy / Q000009:adverse effects / Q000379:methods* / Q000401:mortality / Q000706:statistics & numerical data*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D018579:Patient Selection; D012675:Senegal / Q000453:epidemiology; D017678:Sex Distribution; D015996:Survival Rate; D016896:Treatment Outcome